Activation of the phosphatidylinositol 3-kinases (PI3Ks)/Akt/mammalian target of rapamycin (mTOR) pathway plays a vital role in cancer growth and survival and targeted therapies aimed to reverse endocrine resistance [27]. The gene discussed is AKT1; the disease is cancer.